Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

By R. Brodsky, N. Young, E. Antonioli, A. Risitano, H. Schrezenmeier, J. Schubert, A. Gaya, L. Coyle, Carlos M. de Castro, C. Fu and 5 more. Blood, 2008

647 citations recorded by the source corpus.

Subfields: Immunology, Nephrology, Physiology

View Paper: https://www.semanticscholar.org/paper/eb9866e17b387bdec49c515311de60ad57ce13f4